IF 6.1 2区 医学 Q1 ONCOLOGY Cancer Pub Date : 2025-01-25 DOI:10.1002/cncr.35734
Leah M. Marcotte MD, MS, Sara Khor PhD, Ashok Reddy MD, MSc, Anna Morenz MD, MS, Karin Nelson MD, MSHS, Nkem Akinsoto MSc, E. Sally Lee PhD, Susan Onstad BA, Edwin S. Wong PhD
{"title":"An analysis of multilevel factor contributions to breast cancer screening inequities in an academic health system","authors":"Leah M. Marcotte MD, MS,&nbsp;Sara Khor PhD,&nbsp;Ashok Reddy MD, MSc,&nbsp;Anna Morenz MD, MS,&nbsp;Karin Nelson MD, MSHS,&nbsp;Nkem Akinsoto MSc,&nbsp;E. Sally Lee PhD,&nbsp;Susan Onstad BA,&nbsp;Edwin S. Wong PhD","doi":"10.1002/cncr.35734","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Breast cancer screening (BCS) inequities are evident at national and local levels, and many health systems want to address these inequities, but may lack data about contributing factors. The objective of this study was to inform health system interventions through an exploratory analysis of potential multilevel contributors to BCS inequities using health system data.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The authors conducted a cross-sectional analysis within a large academic health system including 19,774 individuals who identified as Black (<i>n</i> = 1445) or White (<i>n</i> = 18,329) race and were eligible for BCS. They evaluated individual-level, provider-level, and clinic-level factors. They conducted logistic regression and Blinder-Oaxaca (BO) decomposition analyses to quantitatively estimate the contribution of factors to the mean difference in BCS outcomes between the two racialized groups. They calculated average marginal effects (AME) for the logistic regression models representing the estimated additive probability of receiving BCS in the Black versus White group.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>BCS was completed in 63.7% of Black and 71.7% of White individuals (AME, –0.08; 95% confidence interval (CI), –0.10 to –0.04; <i>p</i> &lt; .001). In the BO decomposition, observed factors explained 13.3% difference in BCS. Lower patient portal use among Black versus White patients had the greatest estimated contribution to the BCS inequity (4.6 percentage points; 95% CI, 3.0–6.2).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Racialized group differences in patient portal use had the greatest estimated contribution to the explained difference in BCS between Black and White individuals. Patient portal use promotion could be considered as a part of multifaceted health system efforts to address BCS inequities.</p>\n </section>\n </div>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"131 3","pages":""},"PeriodicalIF":6.1000,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cncr.35734","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:乳腺癌筛查(BCS)不公平现象在国家和地方层面都很明显,许多医疗系统都希望解决这些不公平现象,但可能缺乏有关促成因素的数据。本研究的目的是利用医疗系统数据对造成乳腺癌筛查不公平的潜在多层次因素进行探索性分析,从而为医疗系统干预措施提供信息:作者在一个大型学术医疗系统内进行了一项横断面分析,该系统包括 19774 名符合 BCS 条件的黑人(n = 1445)或白人(n = 18329)。他们评估了个人层面、医疗服务提供者层面和诊所层面的因素。他们进行了逻辑回归和布林德-瓦哈卡(BO)分解分析,以定量估计各因素对两个种族群体间 BCS 结果平均差异的影响。他们计算了逻辑回归模型的平均边际效应(AME),代表了黑人组与白人组接受 BCS 的估计加总概率:结果:63.7% 的黑人和 71.7% 的白人完成了 BCS(平均边际效应,-0.08;95% 置信区间 (CI),-0.10 至 -0.04;P 结论:黑人和白人接受 BCS 的概率存在种族差异:据估计,患者门户网站使用方面的种族群体差异对黑人和白人之间 BCS 差异的解释贡献最大。推广使用患者门户网站可被视为医疗系统解决 BCS 不平等问题的多方面努力的一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
An analysis of multilevel factor contributions to breast cancer screening inequities in an academic health system

Background

Breast cancer screening (BCS) inequities are evident at national and local levels, and many health systems want to address these inequities, but may lack data about contributing factors. The objective of this study was to inform health system interventions through an exploratory analysis of potential multilevel contributors to BCS inequities using health system data.

Methods

The authors conducted a cross-sectional analysis within a large academic health system including 19,774 individuals who identified as Black (n = 1445) or White (n = 18,329) race and were eligible for BCS. They evaluated individual-level, provider-level, and clinic-level factors. They conducted logistic regression and Blinder-Oaxaca (BO) decomposition analyses to quantitatively estimate the contribution of factors to the mean difference in BCS outcomes between the two racialized groups. They calculated average marginal effects (AME) for the logistic regression models representing the estimated additive probability of receiving BCS in the Black versus White group.

Results

BCS was completed in 63.7% of Black and 71.7% of White individuals (AME, –0.08; 95% confidence interval (CI), –0.10 to –0.04; p < .001). In the BO decomposition, observed factors explained 13.3% difference in BCS. Lower patient portal use among Black versus White patients had the greatest estimated contribution to the BCS inequity (4.6 percentage points; 95% CI, 3.0–6.2).

Conclusion

Racialized group differences in patient portal use had the greatest estimated contribution to the explained difference in BCS between Black and White individuals. Patient portal use promotion could be considered as a part of multifaceted health system efforts to address BCS inequities.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer
Cancer 医学-肿瘤学
CiteScore
13.10
自引率
3.20%
发文量
480
审稿时长
2-3 weeks
期刊介绍: The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research
期刊最新文献
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges. Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer. Higher rates of long-term complications after prostate cancer treatment Reduced long-term side effects with MRI-guided radiotherapy in prostate cancer A retrospective study of outcomes across time and treatment regimens in newly diagnosed, FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1